iifl-logo-icon 1

Emmessar Biotech & Nutrition Ltd Share Price

48.13
(-4.99%)
Jul 16, 2024|12:14:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open48.13
  • Day's High49.99
  • 52 Wk High54
  • Prev. Close50.66
  • Day's Low48.13
  • 52 Wk Low21.1
  • Turnover (lac)3.4
  • P/E33.77
  • Face Value10
  • Book Value14.82
  • EPS1.5
  • Mkt. Cap (Cr.)24.07
  • Div. Yield0
No Records Found

Emmessar Biotech & Nutrition Ltd KEY RATIOS

Sector

Chemicals

Open

48.13

Prev. Close

50.66

Turnover(Lac.)

3.4

Day's High

49.99

Day's Low

48.13

52 Week's High

54

52 Week's Low

21.1

Book Value

14.82

Face Value

10

Mkt Cap (₹ Cr.)

24.07

P/E

33.77

EPS

1.5

Divi. Yield

0

Emmessar Biotech & Nutrition Ltd Corporate Action

14 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

27 Oct 2023

12:00 AM

EGM

arrow

24 Aug 2023

12:00 AM

AGM

Announcement Date: 24 Aug, 2023

arrow

Emmessar Biotech & Nutrition Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Emmessar Biotech & Nutrition Ltd SHAREHOLDING SNAPSHOT

16 Jul, 2024|12:20 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 59.52%

Foreign: 0.00%

Indian: 59.52%

Non-Promoter- 0.19%

Institutions: 0.19%

Non-Institutions: 40.27%

Custodian: 0.00%

Share Price

Emmessar Biotech & Nutrition Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

5

5

5

5

Preference Capital

0

0

0

0

Reserves

1.67

1.17

0.7

-0.73

Net Worth

6.67

6.17

5.7

4.27

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

0.36

6.99

3.39

1.26

yoy growth (%)

-94.77

105.85

168.84

-51.65

Raw materials

-0.12

-3.53

-1.54

-0.62

As % of sales

34.4

50.52

45.37

49.55

Employee costs

-0.77

-0.63

-0.57

-0.4

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

0.93

2.25

1

0.79

Depreciation

-0.09

-0.05

-0.05

-0.05

Tax paid

-0.45

-0.8

0.01

0.11

Working capital

0.52

1.83

1.28

-0.03

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-94.77

105.85

168.84

-51.65

Op profit growth

-205.7

-308.67

0.71

-275.86

EBIT growth

-58.68

125.09

25.84

-33.27

Net profit growth

-67.21

92.35

-17.48

-23.14

View Ratios

No Record found

Emmessar Biotech & Nutrition Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

3,171.25

89.561,61,292.74354.320.52,588.88163.92

Linde India Ltd

LINDEINDIA

8,714

174.3174,312.99104.330630.07402.73

SRF Ltd

SRF

2,398.05

51.8871,084.16437.10.32,857.61353.96

Deepak Nitrite Ltd

DEEPAKNTR

2,802.5

102.6938,224.15115.680.27671.15216.61

Gujarat Fluorochemicals Ltd

FLUOROCHEM

3,283.65

86.1436,070.986.010.091,043.2539.16

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Emmessar Biotech & Nutrition Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

MSR Ayyangar

Non Executive Director

Anuradha Raghavan

Non Executive Director

Sarada Raghavan

Independent Director

Anantharama Sethmani Subramanian

Executive Director & CFO

Jayavel Balaiah Nadar

Non Executive Director

Rajalakshmi Srinivasa Raghavan

Company Sec. & Compli. Officer

Priyanka Omprakash Sharma

Independent Director

Milind S Desai

Addtnl Independent Director

Dinesh Kumar Deora

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential.On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.ECILs research team established that the specialty chemicals made by them had potential as Vital Micro Nutrients, used worldwide in research as tools of Biotechnology. The Companys management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturers and consumers minds.EBNLs R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the US
Read More

Company FAQs

What is the Emmessar Biotech & Nutrition Ltd share price today?

Down Arrow

The Emmessar Biotech & Nutrition Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹48.13 today.

What is the Market Cap of Emmessar Biotech & Nutrition Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Emmessar Biotech & Nutrition Ltd is ₹24.07 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Emmessar Biotech & Nutrition Ltd?

Down Arrow

The PE and PB ratios of Emmessar Biotech & Nutrition Ltd is 33.77 and 3.42 as of 16 Jul ‘24

What is the 52 Week High and Low of Emmessar Biotech & Nutrition Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Emmessar Biotech & Nutrition Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Emmessar Biotech & Nutrition Ltd is ₹21.1 and ₹54 as of 16 Jul ‘24

What is the CAGR of Emmessar Biotech & Nutrition Ltd?

Down Arrow

Emmessar Biotech & Nutrition Ltd's CAGR for 5 Years at 25.23%, 3 Years at 1.60%, 1 Year at 103.13%, 6 Month at 89.74%, 3 Month at 38.79% and 1 Month at 33.81%.

What is the shareholding pattern of Emmessar Biotech & Nutrition Ltd?

Down Arrow

The shareholding pattern of Emmessar Biotech & Nutrition Ltd is as follows:
Promoters - 59.53 %
Institutions - 0.20 %
Public - 40.28 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.